|
|
Volumn 191, Issue 1, 2014, Pages 9-10
|
|
Novel urinary markers for detection of bladder cancer - Are we failing?
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
TUMOR MARKER;
BIOLOGICAL MARKER;
BLADDER CANCER;
BLADDER STONE;
CANCER CYTODIAGNOSIS;
CANCER DIAGNOSIS;
CANCER GROWTH;
CANCER RESEARCH;
CANCER SURVIVOR;
CLINICAL DECISION MAKING;
COST EFFECTIVENESS ANALYSIS;
CYSTITIS;
DIAGNOSTIC ACCURACY;
DIAGNOSTIC TEST;
EDITORIAL;
EXTERNAL VALIDITY;
HEALTH CARE COST;
HEMATURIA;
HIGH THROUGHPUT SCREENING;
HUMAN;
METHODOLOGY;
MOLECULARLY TARGETED THERAPY;
PRACTICE GUIDELINE;
PREDICTIVE VALUE;
PRIORITY JOURNAL;
PROSTATE HYPERTROPHY;
RECURRENCE RISK;
REPRODUCIBILITY;
SENSITIVITY AND SPECIFICITY;
TRANSLATIONAL RESEARCH;
TREATMENT FAILURE;
URINALYSIS;
URINARY TRACT CANCER;
URINE CYTOLOGY;
CLINICAL PRACTICE;
CONTROLLED CLINICAL TRIAL (TOPIC);
NOTE;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
SOCIOECONOMICS;
BIOMEDICAL RESEARCH;
HUMANS;
TUMOR MARKERS, BIOLOGICAL;
URINARY BLADDER NEOPLASMS;
|
|
EID: 84890129616
PISSN: 00225347
EISSN: 15273792
Source Type: Journal
DOI: 10.1016/j.juro.2013.10.056 Document Type: Editorial |
|
Times cited : (4)
|
|
References (10)
|
